Q3 2025 Holdings
Filed 2025-11-14 | 23 holdings | $573.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $256.7M | 6,371,669 | 44.8% |
| Nuvation Bio Inc.(NUVB) | COM | 67080N101 | $96.0M | 25,954,439 | 16.8% |
| Upstream Bio Inc.(UPB) | COM | 91678A107 | $61.8M | 3,285,293 | 10.8% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $52.1M | 3,917,299 | 9.1% |
| Newamsterdam Pharma Co NV(NAMS) | COM | N62509109 | $18.7M | 657,051 | 3.3% |
| Merus NV | COM | N5749R100 | $17.6M | 186,546 | 3.1% |
| Revolution Medicines Inc(nsm)(RVMD) | COM | 76155X100 | $9.8M | 210,000 | 1.7% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $9.7M | 595,466 | 1.7% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $7.8M | 4,286,104 | 1.4% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $7.7M | 4,041,736 | 1.3% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $7.4M | 547,609 | 1.3% |
| Equillium Inc.(EQ) | COM | 29446K106 | $6.4M | 4,447,308 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $6.0M | 143,000 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $5.7M | 32,300 | 1.0% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $3.2M | 515,555 | 0.6% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $2.0M | 1,323,327 | 0.3% |
| Moonlake Immunotherapeutics | COM | G4444C102 | $1.3M | 181,600 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $806.0K | 92,748 | 0.1% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $757.8K | 7,979 | 0.1% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $725.5K | 326,810 | 0.1% |
| Grail Inc(GRAL) | COM | 384747101 | $572.6K | 9,684 | 0.1% |
| Rezolute Inc(RZLT) | COM | 76200L309 | $563.1K | 59,900 | 0.1% |
| Nuvation Bio Inc.(NUVB/WS) | WARRANTS | 67080N119 | $115.5K | 646,057 | 0.0% |